School of Medicine
Showing 1-10 of 24 Results
-
Fumiaki Ikeno
Program Director (U.S) Japan Biodesign, Stanford Biodesign, Medicine - Med/Cardiovascular Medicine
Bio Program Director (U.S) Japan Biodesign, Stanford Biodesign
Cardiovascular Medicine, Stanford University
Dr. Ikeno is a Research Associate, Cardiovascular Medicine, Stanford University. In this role, he is responsible for pre clinical studies including GLP for medical devices and also regenerative medicines for cardiovascular diseases. Currently, he is devoting himself to the international regulatory project between Japan and the United States, also known as "Harmonization by Doing", whose focus is to collaborate with regulatory agencies such as FDA, PMDA/MHLW, academia and industries for improving the regulatory process in the 2 largest medtech markets. Dr. Ikeno also devoted himself to found Japan biodesign program which is a collaborative program with University of Tokyo, Osaka University, Tohoku University, Japan Federation Medical Device Association, Ministry of Education Japan and Stanford biodesign program. Currently, Dr. Ikeno serves as the Program Director (US) for Japan Biodesign. Dr. Ikeno is co-founder and board member of US-Japan MedTech Frontier which is a non-profit cooperate to make a trans-pacific eco-system of medical device between Japan and USA.
After 9 years clinical practice as an interventional cardiologist and Family Doctor in rural areas of Japan, Dr. Ikeno came to Stanford as a Researcher and completed his Biodesign Certificate Program. Being part of the ecosystem in Silicon Valley, Dr. Ikeno participated in more than 200 medtech projects and 50 GLP studies as well as in the analysis of clinical trials for cardiovascular medicine (BARI2D, FAME, ReOPEN etc). His other academic consortium projects include Peripheral Academic Research Consortium, Global Consensus Working Group of Optical Coherence Tomography, and Japan-US consensus document for the treatment of critical limb ischemia.
Over the last decade, Dr. Ikeno has served as an advisor for medical device industries and currently serves as a chief medical officer of an incubation fund specific for medtech (Medventure Partners, Inc, Tokyo) as a spin-off from Innovation Network Corporation of Japan (INCJ) that is the largest government and private partnership fund in Japan. He is also serving as a chair of cardiovascular working group of APAN (Asian Pacific Advanced Network) that contributes the remote education, research activities, and tele-health using a specialized internet network. Dr.Ikeno is also serving as consulting faculty/lecturer roles in several universities in Japan including University of Tokyo, Osaka University, Tsukuba University etc. Dr. Ikeno has authored over 70 peer reviewed publications and textbooks and has been invited to lecture at international medical conferences. Dr. Ikeno is a council member of U.S.- Japan Council which is a non-profit organization by Japanese American. He is serving as a mentor for START-X MED which is an accelerating program for Stanford related entrepreneurs in medical fields.
Contact Information
Falk CVRC CV007
300 Pasteur Drive
Palo Alto, CA 94305-5406 -
Fatih Inci
Basic Life Sci Res Assoc, Rad/Canary Center at Stanford for Cancer Early Detection
Current Role at Stanford Dr. Fatih Inci’s area of excellence in research is to create micro- and nano-scale platform technologies at the intersection of medicine, biomedical engineering, biotechnology, chemistry, and materials science by manipulating biomolecules, cells and viruses in small volumes that offers precise solutions for real-world challenges in clinical diagnostics, personalized medicine, early cancer detection, forensic science, and biomarker discovery.
SOME OF THE RESEARCH HIGHLIGHTS and NEWS
•New device selects healthy sperm (Stanford Medicine) (2018).
•WPI Researchers Play Critical Role to Create Sperm-Sorting Device That Could Improve IVF Success (Worcester Polytechnic Institute) (2018).
•Sperm ‘obstacle course’ created by scientists to select healthiest ones for IVF (The Independent UK) (2018).
•Separating the weak from the strong: New device sorts sperm (Scope by Stanford Medicine) (2018).
•Interview on Istanbul University, Science Faculty - Faculty Guide (2017).
•Bioengineering and Biomedicine - Interview on Crossing Paths (2017).
•RöporTAF Interview on TAV Network (2017).
•Scientists develop new HIV diagnostic device (Johns Hopkins News-Letter) (2016).
•Potential point-of-care diagnostic platform (EurekAlert – Science AAAS) (2015).
•A New Platform for Point-of-Care Diagnostics? (Optics&Photonics News) (2015).
•Universelle Diagnostik: Ein Bluttest für alles (Deutschlandfunk) (2015).
•Smarter, Cheaper Technologies Offer Improved Point-of-care Medicine (NIH – National Institue of Biomedical Imaging and Bioengineering) (2015).
•New HIV Test May Improve Point-of-care Medicine in Remote Regions (Journal of the American Medical Association (JAMA)) (2015).
•New Biosensing Platform to be used in Disease Detection (Dartmouth University)
•Paper and Phones Could Soon Diagnose Ebola and HIV for $1 (Newsweek) (MSN News) (2015).
•Biosensing Films and Smartphones Let Doctors Diagnose Disease from Anywhere (Popular Science) (2015).
•Bientôt un diagnostic médical avec son smartphone (Futura Sciences) (2015).
•Novel Biosensing Platform Could Remotely Diagnose Disease And Monitor Treatment (BioSpace) (2015).
•Smarter, cheaper technologies for improved point-of-care medicine in remote areas (Kurzweil Accelerating Intelligence) (2015).
•App may detect bacterial infections (TV news in WPLG TV, an affiliate of ABC News) (2015).
•Un sistema permite diagnosticar enfermedades por el cellular (Investigacion y Desarrollo) (2015).
•Smartphone accessory puts HIV diagnosis in doctors' pockets (Engadget) (2015).
•Cell Phone App Detects Bacteria and Infectious Diseases (HCP Live) (2015).
•New Biosensing Platform Could Quickly and Accurately Diagnose Disease and Monitor Treatment Remotely (Florida Atlantic University) (2015).
•Smart phone diagnosis? Biosensing platform quickly and accurately diagnoses disease and monitors treatment remotely (ScienceDaily) (2015).
•Smartphone App Detects Bacteria, Diseases (Highlights in Product, Design & Development) (Nature World News) (2015).
•Novel biosensing platform could remotely determine treatment options for HIV, E-coli (News-Medical Net) (2015)
•Nanomechanical motion of Escherichia coli adhered to a surface – (Canary Center at Stanford Newsletter) (2014).
•And so they beat on, flagella against the cantilever – (American Institute of Physics) (Phys.org) (EurekAlert – Science AAAS) (ScienceDaily) (Kurzweil Accelerating Intelligence) (2014).
•It’s flagella against the Cantilever for the fate of bacteria – (Boston University) (Science 2.0) (2014).
•Palo Alto Weekly - Stoking a passion for science (News Cover) (2014).
•Disposable Chips to Detect Antiepileptic Drug Serum Concentrations at the Point of Care using Nanoplasmonic Platform – Brigham & Women’s Hospital, BRIght Future Prize (Nature Medicine) (Brigham & Women’s Hospital) (2013).
